Research Article| Volume 85, ISSUE 3, P185-193, February 01, 1997



      The aim of this study was to investigate the hemostatic system in menopausal women before and after three months of treatment with transdermal estradiol (TTS 50, 50 μg/die, n=13) or conjugated equine estrogen (CEE, 0.625 mg/die, n=9) by evaluating : beta-thromboglobulin, platelet factor 4, factor VIIag, factor VIIc, fibrinopeptide A-FPA-, thrombin-antithrombin-TAT-complexes, antithrombin-AT-activity, protein C, plasma fibrinolytic activity (euglobulin clot lysis time), plasminogen and antiplasmin activity. FPA levels significantly increased during TTS 50 treatment (p<0.001) while protein C showed a slight but significant decrease in both treatments (TTS 50 p<0.001, CEE p< 0.05). TAT complexes and AT were found unaltered. Platelet function and fibrinolytic activity did not significantly change. A significant relationship between FPA and estradiol levels, which were significantly increased during TTS 50 therapy, was found (r = 0.40, p<0.05). These findings indicate that unopposed estradiol given by transdermal route induces a slight but significant blood clotting activation, which seems strictly related to its biological activity. Copyright © 1997 Elsevier Science Ltd


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Thrombosis Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • KANNEL W.B
        • HJORTLAND M
        • McNAMARA P.M
        • GORDON T
        Menopause and risk of cardiovascular disease : the Framingham Study.
        Ann Intern Med. 1976; 85: 447-552
        • COLDITZ G.A
        • WILLETT W.C
        • STAMPFER M.J
        • ROSNER B
        • SPEIZER F.E
        • HENNEKENS C.H
        Menopause and the risk of coronary heart disease in women.
        New Engl J Med. 1987; 316: 1105-1110
        • BUSH T.L
        • COWAN L.D
        • CRIQUI M.H
        • WALLACE R.B
        • SUCHINDRAN C.M
        • TYROLER H.A
        • RIKFIND B.M
        Cardiovascular mortality and non-contraceptive estrogen use in women : results from the Lipid Research Clinics Program Follow-up Study.
        Circulation. 1987; 75: 1102-1109
      1. COLLINS, P., ROSANO, G.M.C., JIANG, C., LINDSAY, D., SARREL, P.M. and POOLE-WILSON, P.A. Cardiovascular protection by oestrogen. A calcium antagonist effect? Lancet 341, 1264–5, 1993.

        • STANCZYK F.Z
        • LEVIN J.H
        • D'ABLAING G
        • VIJOD M.A
        • SHAHBAZIAN V.L
        • LOBO R.A
        Decreased in vitro production of 6-keto-prostaglandin by uterine arteries from postmenopausal women.
        Am J Obstet Gynecol. 1989; 161: 1677-1681
        • YLIKORKALA O
        • PUOLAKKA J
        • VRINIKKA L
        Vasoconstrictory thromboxane A2 and vasodilatory prostacyclin in climateric women : effect of oestrogen-progestogen therapy.
        Maturitas. 1984; 5: 201-205
        • JIANG C
        • SARREL P.M
        • POOLE-WILSON P.A
        • COLLINS P
        Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin −1.
        Am J Physiol. 1992; 263: H 271-H275
        • HAYASHI T
        • FUKUTO J.M
        • IGNARRO L.J
        • CHAUDHURI G
        Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis.
        Proc Natl Acad Sci USA. 1992; 89: 1259-1263
        • LA VECCHIA C
        • FRANCESCHI S
        • DECARLI A.S
        • PAMPALLONA S
        • TOGNONI G
        Risk factors for myocardial infarction in young women.
        Am J Epidemiol. 1987; 125: 832-843
        • THOMPSON S.G
        • MEADE T.W
        • GREENBERG G
        The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in young women.
        J Epidemiol Community Health. 1989; 43: 173-178
        • WILSON P.W.F
        • GARRISON R.J
        • CASTELLI W.P
        Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50.
        N Engl J Med. 1985; 313: 1038-1043
        • STAMPFER M.J
        • WILLETT W.C
        • COLDITZ G.A
        • SPEIZER F.E
        • HENNEKENS C.H
        A prospective study of past use of oral contraceptive agents and risk of cardiovascular diseases.
        N Engl J Med. 1988; 319: 1313-1317
        • VESSEY M.P
        • McPHERSON K
        • YEATES D
        Mortality among oral contraceptive users : 20 -year follow up of women in a cohort study.
        BMJ. 1989; 299: 1487-1491
        • CHETKOWSKI R.J
        • MELDRUM D.R
        • STEINGOLD K.A
        • RANDLE D
        • LU J.K
        • EGGENA P
        • HERSHMAN J.M
        • ALKJAERSIG N.K
        • FLETCHER A.P
        • JUDD H.L
        Biologic effects of transdermal estradiol.
        N Engl J Med. 1986; 314: 1615-1620
        • ALKJAERSIG N
        • FLETCHER A.P
        • DE ZEIGLER D
        • STEINGOLD K.A
        • MELDRUM D.R
        • JUDD H.L
        Blood coagulation in postmenopausal women given estrogen treatment: comparison of transdermal and oral administration.
        J Lab Clin Med. 1988; 111: 224-228
        • CORTELLARO M
        • NENCIONI T
        • BOSCHETTI C
        • ORTOLANI S
        • BUZZI F
        • FRANCUCCI B
        • CARACENI M.P
        • ABELLI P
        • POLVANI F
        • ZANUSSI C
        Cyclic hormonal replacement therapy after the menopause : transdermal versus oral treatment.
        Eur J Clin Pharmacol. 1991; 41: 555-559
        • BOSCHETTI C
        • CORTELLARO M
        • NENCIONI T
        • BERTOLLI V
        • DELLA VOLPE A
        • ZANUSSI C
        Short and long-term effects of hormone replacement therapy (transdermal estradiol vs oral coniugated equine estrogens, combined with medroxyprogesterone acetate) on blood coagulation factors in postmenopausal women.
        Thromb Res. 1991; 62: 1-8
        • BALFOUR J.A
        • HEEL R.C
        Transdermal estradiol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of menopausal complaints.
        Drugs. 1990; 40: 561-582
      2. BELLON, J.L., CASTELLANOS, C., ACEVEDO, L. and AMIRAL, J. Measurement of beta-thromboglobulin and platelet factor 4 to follow up patients with artificial heart valves. Semin Thromb Hemost 19 Suppl 1, 178–82, 1993.

        • TIRINDELLI M.C
        • MAZZUCCONI A
        • MARIANI G
        A new method for evaluation of factor VII antigen by ELISA.
        Am J Haematol. 1987; 26: 313-321
      3. AUSTEN, D.E.G. and RYHMES, I.L. A Laboratory Manual of Blood Coagulation. Blackwell Scientific Publications, Oxford (1975).

        • SORIA J
        • SORIA C
        • RYCKEWAERT J.J
        A solid phase immuno enzymological assay for the measurement of human fibrinipeptide A.
        Thromb Res. 1980; 20: 425-429
        • PELZER H
        • SCHWARZ A
        • HEIMBURGER N
        Determination of human thrombin- antithrombin III complex in plasma with an enzyme-linked immunosorbent assay.
        Thromb Haemost. 1988; 59: 101-106
        • PHILO R.D
        • GAFFNEY P.J
        Comparison of antithrombin III assays using biological and chromogenic substrates.
        Br J Haematol. 1982; 50: 147-156
        • BERTINA R.M
        • BROEKMANS A.W
        The use of a functional and immunologic assay for protein C in the study of heterogeneity of congenital protein C deficiency.
        Thromb Haemost. 1984; 51: 1-5
        • JANUSZKO T
        • DUBINSKA L
        Estimation of the activator of fibrinolysis by means of the euglobulin test.
        Acta Med Pol. 1965; 6: 269-275
        • HUSEBY R.M
        • SMITH R.E
        Synthetic oligopeptide substrates. Their diagnostic application in blood coagulation, fibrinolysis, and other pathologic states.
        Semin Thromb Hemost. 1980; 6: 173-179
        • RATTLE S.J
        • PURNELL D.R
        • WILLIAMS P
        • SIDDLE K
        • FORREST G.C
        New separation method for monoclonal immunoradiometric assays and its application to assay for thyrotropin and human choriogonadotropin.
        Clin Chem. 1984; 30: 1457-1462
        • MALVANO R
        Recent trends in methodological simplification of steroid radioimmunoassay.
        Horm Res. 1978; 9: 422-426
        • BAR J
        • TEPPER R
        • FUCHS J
        • PARDO Y
        • GOLDBERGER S
        • OVADIA J
        The effect of estrogen replacement therapy on platelet aggregation and adenosine triphosphate release in postmenopausal women.
        Obstet Gynecol. 1993; 81: 261-264
        • ABBATE R
        • PINTO S
        • ROSTAGNO C
        • BRUNI V
        • ROSATI D
        • MARIANI G
        Effects of long-term gestodene-containing oral contraceptive administration on hemostasis.
        Am J Obstet Gynecol. 1990; 163: 424-429
      4. PINTO, S., ROSTAGNO, C., COSTANZO, M., COSTANZO, G., BRUNI, V., ROSATI, D. and ABBATE, R. Effects of ethinyl estradiol reduction in oral contraceptives on thrombin generation. In : Progress in Gynecology and Obstetrics. A.R. Genazzani, F. Petraglia and A. Volpe (eds.) pp 741–746, The Parthenon Publishing Group Carnforth-Park Ridge (1990).

        • CAINE Y.G
        • BAUER K.A
        • BARZEGAR S
        • TEN CATE H
        • SACKS F.M
        • WALSH B.W
        • SCHIFF I
        • ROSENBERG R.D
        Coagulation activation following estrogen administration to postmenopausal women.
        Thromb Haemost. 1992; 68: 392-395
        • FOX J
        • GEORGE A.J
        • NEWTON J.R
        • PARSONS A.D
        • STUART G.K
        • STUART J
        • STURDEE D.W
        Effect of transdermal oestradiol on the haemostatic balance of menopausal women.
        Maturitas. 1993; 18: 55-64